Skip to main content
TipRanks
Go Ultimate75% OFF

Mycronic AB (MYCR) AI Stock Analysis

6 Followers
SE:MYCR

Mycronic AB

(Nasdaq OMX AB:MYCR)

Select Model
Rating:76Outperform
Price Target:SEK 340.00â–²(17.24% Upside)
Action:reiterated
Date:10/23/26

Mycronic’s strong profitability, high returns, and very low leverage are the primary strengths. These are moderated by weaker free-cash-flow conversion, bearish short-term technical momentum, and a relatively high P/E ratio despite the low dividend yield.

Positive Factors
Premium profitabilityMycronic’s strong gross, operating, and net margins indicate valuable technology, pricing power, and disciplined execution. Sustained profitability should support internal funding for research, product development, and customer support while providing resilience through normal industrial demand fluctuations.
Negative Factors
Weak cash conversionThe gap between reported earnings and cash generation reduces visibility into how efficiently profits become deployable funds. If this pattern persists, working-capital or investment demands could constrain internally funded growth and make cash available for shareholder returns or strategic investment less predictable.

Mycronic AB (MYCR) vs. iShares MSCI Sweden ETF (EWD)

-20%0%20%40%60%80%SE:MYCR+43.37%EWD+15.64%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
SEK 56.79B
Dividend Yield
1.12%
Average Volume (3M)
284.64K
Price to Earnings (P/E)
28.5
Beta (1Y)
0.83
Revenue Growth
16.55%
EPS Growth
14.12%
Country
Sweden
Employees
2,875
Sector
General
Sector Strength
55
Industry
Industrial - Machinery

Mycronic AB Business Overview & Revenue Model

Company Description

Mycronic AB (publ), based in Täby, Sweden, is a global entity dedicated to the creation, production, and sale of advanced manufacturing machinery for the electronics sector. The company operates extensively across Sweden, wider Europe, North and Sout...

How the Company Makes Money

Mycronic makes money primarily by selling high-value capital equipment used in electronics manufacturing and by generating recurring revenue from supporting that installed base. Key revenue streams typically include: (1) System/equipment sales: one-t...

Mycronic AB Financial Statement Overview

Summary

Strong financial profile, supported by improving profitability, a 25.4% return on equity, and exceptionally low debt-to-equity of 4.9%. Cash-flow quality is the main weakness because free cash flow declined to 999 million and conversion from net income weakened.

Income Statement

90Very Positive

Balance Sheet

95Very Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue9.30B7.94B7.06B5.71B5.12B4.63B
Gross Profit5.00B4.12B3.72B2.72B2.29B2.28B
EBITDA3.06B2.30B2.37B1.51B1.16B1.26B
Net Income1.99B1.56B1.68B998.00M741.00M828.00M
Balance Sheet
Total Assets13.24B10.92B10.41B8.34B7.34B6.14B
Cash, Cash Equivalents and Short-Term Investments3.27B2.32B3.01B2.14B1.27B683.00M
Total Debt415.00M348.00M219.00M228.00M270.00M243.00M
Total Liabilities4.74B3.81B3.84B3.06B2.64B2.14B
Stockholders Equity8.50B7.11B6.53B5.25B4.66B3.96B
Cash Flow
Free Cash Flow999.00M1.32B1.64B1.41B712.00M908.00M
Operating Cash Flow2.41B1.41B1.87B1.61B853.00M998.00M
Investing Cash Flow-462.00M-1.13B-500.00M-195.00M67.00M-1.22B
Financing Cash Flow-818.00M-862.00M-552.00M-447.00M-382.00M-437.00M

Mycronic AB Technical Analysis

Technical Analysis SentimentNegative
Last Price290.00

Price Trends

50DMA316.30Negative
100DMA318.66Negative
200DMA284.84Positive

Market Momentum

MACD-7.84Negative
RSI42.61Neutral
STOCH73.71Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:MYCR, the sentiment is Negative. The current price of 290.00 is below the 20-day moving average (MA) of 295.38, below the 50-day MA of 316.30, and above the 200-day MA of 284.84, indicating a neutral trend. The MACD of -7.84 indicates Negative momentum. The RSI at 42.61 is Neutral, neither overbought nor oversold. The STOCH value of 73.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:MYCR.

Mycronic AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

SE:MYCR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:MYCRSE:MYCR76OutperformSEK 56.79B28.4625.38%1.12%16.55%14.12%
SE:ATCO.BSE:ATCO.B73OutperformSEK 898.02B33.9124.21%2.98%2.72%0.11%
SE:ALFASE:ALFA67NeutralSEK 226.50B27.8317.58%1.64%4.27%-2.41%
SE:SANDSE:SAND65NeutralSEK 454.21B23.8118.92%1.66%14.34%29.04%
SE:MTRSSE:MTRS60NeutralSEK 24.99B47.0710.12%1.17%-0.19%78.46%
SE:NMANSE:NMAN60NeutralSEK 5.14B22.91―2.73%-6.05%-24.08%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-25%0%25%50%75%SE:MYCRSE:ALFASE:ATCO.BSE:SANDSE:MTRSSE:NMANDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SE:MYCR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SE:MYCRMycronic AB290.0085.2541.64%
SE:ALFAAlfa Laval AB548.00108.9324.81%
SE:ATCO.BAtlas Copco AB (0R82)168.0033.6925.09%
SE:SANDSandvik AB (UK)362.1081.7529.16%
SE:MTRSMunters Group AB136.80-25.24-15.58%
SE:NMANNederman Holding AB146.40-6.38-4.18%

Mycronic AB Corporate Events

Mycronic Lifts 2026 Sales Outlook as Global Technologies Drives Earnings Surge

Oct 22, 2026

Mycronic AB reported a robust third quarter, with order intake up 10 percent to SEK 2,667 million and net sales jumping 38 percent to SEK 2,356 million, driven mainly by strong performance in Global Technologies across all divisions. EBIT more than d...

Mycronic Names Mikael Wahlsten to Lead Pattern Generators Division

Oct 21, 2026

Mycronic AB has appointed longtime executive Mikael Wahlsten as Senior Vice President Pattern Generators and member of the executive management team, effective November 1, 2026, succeeding Charlott Samuelsson, who is retiring after three decades with...

Mycronic Wins SLX Mask Writer Order to Support European Chip Modernization

Oct 20, 2026

Mycronic AB has received an order worth between USD 5 million and USD 7 million from an existing customer for its SLX laser mask writer, scheduled for delivery to a European site in the third quarter of 2027. The deal underscores growing demand for m...

Mycronic Wins U.S. Order for Two SLX Semiconductor Mask Writers

Oct 14, 2026

Mycronic AB has secured an order from a U.S. customer for two SLX laser mask writers, with a total value estimated between USD 14 million and USD 16 million and delivery scheduled for the first quarter of 2028. The SLX systems, which share technology...

Mycronic sets date for Q3 2026 report and investor webcast

Oct 8, 2026

Mycronic has scheduled the release of its third-quarter 2026 report for October 22, 2026, at 8:00 a.m. CEST, followed by a webcast presentation at 10:00 a.m. CEST for analysts, investors and media. The event, led by President and CEO Anders Lindqvist...

Mycronic Appoints Nomination Committee for 2027 AGM

Sep 15, 2026

Mycronic AB has appointed the Nomination Committee for its 2027 Annual General Meeting in line with instructions approved at the 2026 AGM. The committee consists of representatives from major shareholders Bure Equity, SEB Funds and the Fourth Swedish...

Mycronic Sets Ambitious Long-Term Growth and Profitability Targets

Aug 31, 2026

Mycronic has set new long-term financial targets, aiming to lift net sales to SEK 20 billion in the period 2032–2035 while maintaining an EBIT margin of around 25 percent. The unchanged sustainability goals and requirement that each division deliver...

Mycronic wins USD 21–24 million Prexision 80 Evo order from Asian display customer

Aug 28, 2026

Mycronic has received a replacement order from an existing Asian customer for a Prexision 80 Evo mask writer, a high-end system designed to meet the demanding requirements of complex display photomasks. The order, valued between USD 21 million and US...

Mycronic wins new Asian order for SLX semiconductor mask writer

Aug 13, 2026

Mycronic’s Pattern Generators division, which supplies mask writers and metrology systems for display and semiconductor manufacturing, has secured a new customer in Asia for its SLX laser mask writer. The order, valued between USD 4 million and 6 mil...

Mycronic wins Asian order for SLX laser mask writer

Jul 23, 2026

Mycronic has secured an order valued between USD 5 million and 7 million from an existing customer in Asia for its SLX laser mask writer, with delivery scheduled for the second quarter of 2027. The SLX system, which leverages technology from Mycronic...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 23, 2026